A Review of Personalised Molecular Medicine for the Treatment of Corneal Disorders

Journal Title: International Journal of Ophthalmology & Eye Science (IJOES) - Year 2015, Vol 0, Issue 6

Abstract

The cornea represents an ideal tissue to elucidate the potential of molecular medicine to treat genetic disorders. It is a small, readily accessible tissue that is easy to monitor treat topically, while a number of corneal disorders are well characterized with regard to a known genetic cause. In addition, due to their genetic basis most of these conditions are bilateral, affecting both corneas, allowing for a clear comparison between treated and untreated tissue using the fellow eye as a control. Currently, molecular techniques utilising siRNAs, CRISPR/Cas9, TALENS and ZFNs are being evaluated by many for their therapeutic potential for corneal disorders. Methodologies are discussed within this review with particular emphasis on the more recent and emerging field of CRISPR/Cas9-based therapeutics. Since the advent of gene therapies, effective delivery has been a challenge. Potential ocular delivery techniques include viral vectors, nanoparticles or physical injection. Studies employing in vitro and in vivo models of corneal disorders have demonstrated promising results for treatment by molecular techniques. However, many of these studies have not translated into the clinic, perhaps due to a lack of good animal models for preclinical testing or failure to develop suitable delivery methods.Until this occurs it is difficult to fully gauge the usefulness of these techniques to treat corneal disorders in human patients over a sustained time period. Here we present a review of current research into molecular-based therapies for genetic corneal disorders and discuss the applicability of these studies to advancing translational research for other genetic disorders.

Authors and Affiliations

David G. Courtney

Keywords

Related Articles

IN the Spotlight: The International year of Light

IN the Spotlight: The International year of Light

Conjunctival impression Cytology; An Aid in the Diagnosis of Dry Eye Syndromes

Dry eye syndrome is a multifactorial disease of tears and ocular surface resulting in ocular discomfort, visual disturbances and damage to the ocular surface with tear film instability. Diagnosis is based on symptom base...

Daylight For Healthy Indoor Environment And Energy Benefits

Daylight For Healthy Indoor Environment And Energy Benefits

Phlyctenular Conjunctivitis and Tuberculosis

Introduction: Phlyctenular keratoconjunctivitis is a nodular affliction characterized by the formation of a small, circumscribed lesion at the corneal limbus and now accepted as a morphologic expression of delayed hypers...

Real Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT Study

Background: This subgroup analysis of RE-ENACT study (retrospective, multicenter, observational pooled study on wet age-related macular degeneration [wet AMD], diabetic macular edema, and retinal vein occlusion) evaluate...

Download PDF file
  • EP ID EP200125
  • DOI 10.19070/2332-290X-SI02002
  • Views 76
  • Downloads 0

How To Cite

David G. Courtney (2015). A Review of Personalised Molecular Medicine for the Treatment of Corneal Disorders. International Journal of Ophthalmology & Eye Science (IJOES), 0(6), 7-18. https://europub.co.uk/articles/-A-200125